SMTL ID : 7dv6.1

Discovery of Functionally Selective Transforming Growth Factor beta Type II Receptor (TGF-beta RII) Inhibitors as Anti-Fibrosis Agents

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.39 Å

Oligo State

monomer

Ligands

1 x HJF: 5-[(3S)-5,5-dimethyloxolan-3-yl]-6-methoxy-3-(2-methoxypyridin-4-yl)pyrazolo[1,5-a]pyrimidine(Non-covalent)

HJF.1: 17 residues within 4Å: Chain A: V.16, G.17, V.24, A.41, K.43, L.71, T.91, A.92, F.93, H.94, A.95, G.97, N.98, S.149, L.152, C.162, D.163 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:V.16, A:V.24, A:L.71, A:L.152 Hydrogen bonds: A:H.94, A:N.98, A:N.98 Water bridges: A:K.43, A:D.163

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Miwa, S. et al., Discovery of Selective Transforming Growth Factor beta Type II Receptor Inhibitors as Antifibrosis Agents. Acs Med.Chem.Lett. (2021)

Release Date

2021-06-16

Peptides

TGF-beta receptor type-2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

TGF-beta receptor type-2